The earnings call reflects a company making strides in refranchising and financial performance, as evidenced by increased system-wide sales and EBITDA growth. However, challenges remain with declining new patient traffic and the need to adjust sales guidance due to macroeconomic headwinds. The focus on pain management and technology enhancements show potential for future growth.

Company Guidance

In the recent conference call for the Joint Corp's Second Quarter 2025 financial results, several key metrics and guidance were discussed. System-wide sales for Q2 2025 were reported at $129.6 million, reflecting a 2.6% increase, while comparable sales for clinics open at least 13 months rose by 1.4%. Revenue from continuing operations increased by 5%, and consolidated adjusted EBITDA saw a significant growth of 52%, reaching $3.2 million compared to the same period in 2024. The company reported a net income of $93,000, a notable improvement from a net loss of $3.6 million in Q2 2024. The unrestricted cash and equivalents as of June 30, 2025, stood at $30 million. Looking ahead, the Joint Corp revised its 2025 guidance, projecting system-wide sales between $530 million and $550 million, and a low single-digit increase in comparable sales, while adjusting consolidated EBITDA guidance to a range of $10.8 million to $11.8 million. The call also highlighted the company's strategic transition to a pure-play franchisor, with a focus on refranchising efforts, dynamic revenue management, and enhanced marketing strategies to drive long-term growth and profitability.

Increased System-Wide Sales

System-wide sales were $129.6 million, up 2.6% compared to Q2 2024.

Significant Growth in Adjusted EBITDA

Consolidated adjusted EBITDA grew to $3.2 million, a 52% increase compared to Q2 2024.

Successful Refranchising Efforts

Refranchised 37 clinics, reducing corporate clinics to 8% of the portfolio, and sold 31 corporate clinics in Arizona and New Mexico for $11.1 million.

Strong Financial Liquidity

Unrestricted cash and equivalents reached $30 million as of June 30, 2025.

Launch of New Mobile App

Launched a mobile app with approximately 10% of active patients already using it, aiming to enhance patient experience and extend lifetime value.

Stock Repurchase Program Initiation

The Board authorized a stock repurchase program to repurchase up to $5 million of outstanding common stock.

Joint (JYNT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

JYNT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 06, 2025	2025 (Q3)	0.00 / -	-0.21	―	―	―
Aug 07, 2025	2025 (Q2)	-0.04 / -0.05	-0.24	77.92% (+0.19)
May 08, 2025	2025 (Q1)	<0.01 / -0.03	0.06	-150.00% (-0.09)
Mar 13, 2025	2024 (Q4)	0.01 / -0.18	-0.75	76.00% (+0.57)
Nov 07, 2024	2024 (Q3)	<0.01 / -0.21	-0.05	-320.00% (-0.16)
Aug 08, 2024	2024 (Q2)	-0.02 / -0.24	-0.01	-2300.00% (-0.23)
May 02, 2024	2024 (Q1)	<0.01 / 0.06	0.15	-60.00% (-0.09)
Mar 07, 2024	2023 (Q4)	0.01 / -0.75	0.04	-1975.00% (-0.79)
Nov 09, 2023	2023 (Q3)	0.02 / -0.05	0.03	-266.67% (-0.08)
Aug 10, 2023	2023 (Q2)	0.01 / -0.01	0.02	-150.00% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

JYNT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$10.70	$10.74	+0.37%
May 08, 2025	$10.53	$9.99	-5.13%
Mar 13, 2025	$10.54	$11.02	+4.55%
Nov 07, 2024	$11.88	$11.61	-2.27%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Joint Corp (JYNT) report earnings?

Joint Corp (JYNT) is schdueled to report earning on Nov 06, 2025, After Close (Confirmed).

What is Joint Corp (JYNT) earnings time?

Joint Corp (JYNT) earnings time is at Nov 06, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is JYNT EPS forecast?

JYNT EPS forecast for the fiscal quarter 2025 (Q3) is 0.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing